Top 4 NASDAQ Stocks In The Drugs Generic Industry With The Highest EPS Growth Forecast For Next 5 Years

Below are the top drugs generic stocks on the NASDAQ in terms of EPS growth forecast for the next five years.

Sagent Pharmaceuticals, Inc. (NASDAQ: SGNT) earnings per share growth forecast for the next five years is 70.00%. Sagent Pharmaceuticals' PEG ratio is 0.88.

Evoke Pharma, Inc. (NASDAQ: EVOK) EPS growth forecast for the next five years is 40.00%. Evoke Pharma's trailing-twelve-month EPS is -$1.98.

Akorn, Inc. (NASDAQ: AKRX) EPS growth forecast for the next five years is 33.15%. Akorn's trailing-twelve-month profit margin is 5.10%.

Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) earnings per share growth forecast for the next five years is 19.20%. Avanir Pharmaceuticals' trailing-twelve-month revenue is $115 million.